# NIRTRAKS Post-Market Study (NIRTRAKS)

> **NCT02455804** · NA · COMPLETED · sponsor: **Medinol Ltd.** · enrollment: 65 (actual)

## Conditions studied

- de Novo Stenotic Lesions in Native Coronary Arteries

## Interventions

- **DEVICE:** Stenting procedure

## Key facts

- **NCT ID:** NCT02455804
- **Lead sponsor:** Medinol Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-08
- **Primary completion:** 2020-01-14
- **Final completion:** 2020-01-14
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2023-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02455804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02455804, "NIRTRAKS Post-Market Study (NIRTRAKS)". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT02455804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*